Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases.
Kervarrec ThibaultDanna WestphalDaniel PissalouxMélanie LegrandFranck TirodeAnne NeuhartFrancoise DrouotJürgen C BeckerNicolas MacagnoAlice SerisThomas JouaryFanny BeltzungMarie-Laure JullieKelly L HarmsBernard CribierSamia MourahFanélie JouenneGaelle FromontBaptiste LouveauMaxence ManciniDmitry V KazakovArnaud de la FouchardièreMaxime BattistellaPublished in: Histopathology (2024)
Our study suggests that PAK1/2/3 fusions is the oncogenic driver of a subset of porocarcinomas lacking YAP1 rearrangement.
Keyphrases